DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 2Dr. Reddy's Laboratories
02 1Amnos Lifesciences
03 4Farbe Firma
04 2GLAND PHARMA LIMITED
05 2Hikma Pharmaceuticals
06 1KK BCJ-94
07 1Long Grove Pharmaceuticals
08 5Mitsubishi Tanabe Pharma
09 1Montage Laboratories
10 2PHARMOBEDIENT
11 1Sandoz B2B
12 3Teva Pharma Australia
13 1Yangtze River Pharmaceutical Group
14 1Zydus Pharmaceuticals
Reset all filters
01 1Ampoule
02 1INJECTABLE;INJECTION
03 1INJECTION;SOLUTION
04 1Infusion Solution
05 6Injection
06 1Liquid Injection
07 1Oral Suspension
08 10SOLUTION;INTRAVENOUS
09 1SUSPENSION
10 1SUSPENSION;ORAL
11 3Blank
Reset all filters
01 2Allowed
02 1Lead Market Dossiers- Filed
03 1Prescription
04 11RX
05 12Blank
Reset all filters
01 10EDARAVONE
02 1Edaravone
03 3RADICAVA
04 1RADICAVA ORS
05 5Radicava
06 7Blank
Reset all filters
01 3Australia
02 1Canada
03 1China
04 7India
05 2Switzerland
06 13USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/100ML (0.6MG/ML)
Packaging :
Approval Date : 2024-05-06
Application Number : 215917
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60MG/100ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 30MG/100ML (0.3MG/ML)
Packaging :
Approval Date : 2024-05-06
Application Number : 216199
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/100ML (0.6MG/ML)
Packaging :
Approval Date : 2024-05-06
Application Number : 216199
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 30MG/100ML (0.3MG/ML)
Packaging :
Approval Date : 2024-05-06
Application Number : 215508
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 60mg/100mL
Packaging :
Approval Date :
Application Number : 215508
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 30MG/100ML (0.3MG/ML)
Packaging :
Approval Date : 2024-05-06
Application Number : 218354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RADICAVA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 30MG/100ML (0.3MG/ML)
Packaging :
Approval Date : 2017-05-05
Application Number : 209176
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RADICAVA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/100ML (0.6MG/ML)
Packaging :
Approval Date : 2018-11-15
Application Number : 209176
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 30MG/100ML (0.3MG/ML)
Packaging :
Approval Date : 2024-12-23
Application Number : 216902
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG
Packaging : 5mL:10mgx6amps
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info :
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30MG/100ML(0.3MG/ML)
Packaging :
Approval Date :
Application Number : 218349
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RADICAVA ORS
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 105MG/5ML
Packaging :
Approval Date : 2022-05-12
Application Number : 215446
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 30MG/100ML (0.3MG/ML)
Packaging :
Approval Date : 2024-10-31
Application Number : 217565
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARAVONE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/100ML (0.6MG/ML)
Packaging :
Approval Date : 2024-10-31
Application Number : 217565
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF